Amgen Inc., Biogen Inc., Gilead Inc. and Novo Nordisk A/S all have “very high” capacity for M&A activity, Moody’s Investors Service said in a report...
Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties






